Navigation Links
ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
Date:2/26/2008

growth in pancreatic and breast cancer models and recognizes CD9 on CD34+CD38- leukemic cancer stem cells." Experimental and Molecular Therapeutics 32, Tuesday, April 15, 2008, 8:00 AM

Abstract Number 3995:

"A monoclonal antibody targeting CD59 (AR36A36.11.1), enhances complement activity and exhibits potent in vivo efficacy in multiple human cancer models." Experimental and Molecular Therapeutics 32, Tuesday, April 15, 2008, 8:00 AM

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusresearch.com

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements in this release include, but are not limited to, ARIUS successfully advancing its new product programs as well as licensing opportunities. These statements are only predictions and actual events or results may differ materially. Factors that could cause such actual events or results expressed or implied by such forward-looking statements to differ material
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
2. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
3. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
4. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
5. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
6. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
7. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
8. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
9. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
10. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
11. ARIUS to present at Chinese Global Financial Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...wswire-FirstCall/ -- Insmed Inc. (Nasdaq:,INSM), a...ticals, today,announced that it will host a confer...discuss its results for the second quarter 2008. I...ults press release before the market,opens on Augu...ll, please dial 866-202-1971,(U.S. callers) or 617...
(Date:7/25/2008)...reen Goods Raises Questions about SIGG and Recomme...ord, NH (PRWEB) July 25, 2008 -- These days, when ...ey,re probably sipping water from a SIGG bottle. &...ge of honor but, sadly, it may not be that green,&... Real Green Goods, a NH-based green department sto...
(Date:7/24/2008)...uct Sales Driven by Robust MRSA Growth, SUNNYVALE...d (Nasdaq:,CPHD) today reported revenue for the se... of 55% over the second quarter of fiscal 2007. Ne...ch compares to revenue of,$27.2 million and a net ...,second quarter of fiscal 2007., Excluding amorti...
(Date:7/24/2008)... /- Rochester,Medical Corpo...sults after,financial markets close on Thursday, J...y conference call to discuss its earnings report. ...time (5:00 p.m. eastern time)., This call is bein...ochester Medical,s website at http://www.rocm.com...
Breaking Biology Technology:Insmed to Host Second Quarter 2008 Conference Call 2SIGG Water Bottles: Hip But Not Necessarily Green; Were Madonna and Cindy Crawford Hoodwinked? 2Cepheid Reports Second Quarter Revenue of $42.1 Million 2Cepheid Reports Second Quarter Revenue of $42.1 Million 3Cepheid Reports Second Quarter Revenue of $42.1 Million 4Cepheid Reports Second Quarter Revenue of $42.1 Million 5Cepheid Reports Second Quarter Revenue of $42.1 Million 6Cepheid Reports Second Quarter Revenue of $42.1 Million 7Cepheid Reports Second Quarter Revenue of $42.1 Million 8Cepheid Reports Second Quarter Revenue of $42.1 Million 9Cepheid Reports Second Quarter Revenue of $42.1 Million 10Cepheid Reports Second Quarter Revenue of $42.1 Million 11Cepheid Reports Second Quarter Revenue of $42.1 Million 12Cepheid Reports Second Quarter Revenue of $42.1 Million 13Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31, 2008 2
...ogies is appointing more new top management in th... release. , ,Maneesh Arora, 37, will become CFO af...has held senior positions in marketing and operati...moving on. Gregory Hamilton, 35, will be vice pres... president of sales. He is new to Third Wave, comi...
Milwaukee, Wis. Johnson Controls , well-known for automotive interiors and batteries, is buying a minority stake in a Florida integration company to boost its profile in another field: health car
... K-8 public school available statewide, is holding... the state,s open enrollment program on February 2...computer, monitor, printer and access to the onlin...ther responsible adult and correspond with public ...nts. Since it,s a public school, there is no tuiti...
...iative to establish a citywide wireless network in...a, Wauwatosa and Brookfield are getting into the a...tched by Cellnet, the provider that has made a dea... being built by a different company, Midwest Fiber... city is essentially leasing space or the use of m...
Other Biology Technology:
(Date:7/25/2008)...CHICAGO (July 25, 2008) New research published in...llege of Surgeons shows elevated plasma DNA is a ...e study also suggests that plasma DNA levels rise ...he majority of patients. , Esophageal cancer, ...e, is usually diagnosed at a late stage. An accura...
(Date:7/24/2008)..., Well inside the Arctic Circle, scientists h...yone has ever seen before. The cluster of five ven...e venting water as hot as 570 F., Dissolved sulf...e icy cold of the deep sea have, over the years, a... the most massive hydrothermal sulfide deposits ev...
(Date:7/24/2008)...Researchers at The Pennsylvania State University C...covered that the efficacy of imiquimod, a clinical...antiviral and antitumor activity, is dependent on ... axis for its action. This discovery, reported in...Medicine , provides new insights into a widely use...
(Date:7/24/2008)...GAINESVILLE, Fla. If worms could talk, they might...le," complete with that telltale come slither look...n as pheromones, a complex chemical code researche...d Wednesday (July 23) in the journal Nature . ,...ll University, the California Institute of Technol...
Breaking Biology News(10 mins):Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2Scientists break record by finding northernmost hydrothermal vent field 2Scientists break record by finding northernmost hydrothermal vent field 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3Study Reaffirms Superiority of Trofile 28TM 29 Assay 2309 1Study Reaffirms Superiority of Trofile 28TM 29 Assay 2309 2Study Reaffirms Superiority of Trofile 28TM 29 Assay 2309 3Study Reaffirms Superiority of Trofile 28TM 29 Assay 2309 4Study Reaffirms Superiority of Trofile 28TM 29 Assay 2309 5Study Reaffirms Superiority of Trofile 28TM 29 Assay 2309 6Indevus Receives Non Approvable Letter From FDA for VALSTAR 28TM 29 2306 1Indevus Receives Non Approvable Letter From FDA for VALSTAR 28TM 29 2306 2Indevus Receives Non Approvable Letter From FDA for VALSTAR 28TM 29 2306 3Indevus Receives Non Approvable Letter From FDA for VALSTAR 28TM 29 2306 4Jingle bells not merry for tone deaf individuals 1679 1Jingle bells not merry for tone deaf individuals 1679 2Jingle bells not merry for tone deaf individuals 1679 3Physician scientists seek solutions to reproductive problems related to chromosomal variations 1677 1Physician scientists seek solutions to reproductive problems related to chromosomal variations 1677 2Physician scientists seek solutions to reproductive problems related to chromosomal variations 1677 3
...a nice partner to settle down and raise children w...ralian redback spider. Instead of personality conf...magine that immediately after the first time you h...our body weight -- will eat you alive. , Not the i...t only one mating opportunity -- an uncommon occur...
...ng together in a project called PLANTS, sought to ...logy and people to continuously assess the state o...cialist software, the system monitors the state of...time. , PLANTS adhered to a broader vision where ...rated with the physical environment. One of its ma...
...e working toward a future in which each patient,s ...oncologists should treat the cancer to obtain the ...ict which patients with prostate cancer should rec... of these patients have an indolent disease that d...olorectal cancer have surgery, but some, even at t...
...e working toward a future in which each patient,s ...oncologists should treat the cancer to obtain the ...ict which patients with prostate cancer should rec... of these patients have an indolent disease that d...olorectal cancer have surgery, but some, even at t...
Other Biology News:'Scent of a woman' tells male redback spiders to find a mate 2'Scent of a woman' tells male redback spiders to find a mate 3New crop of technology reveals plant health 2New crop of technology reveals plant health 3AIDS-related cognitive impairment exists in two separate forms 2AIDS-related cognitive impairment exists in two separate forms 3AIDS-related cognitive impairment exists in two separate forms 4AIDS-related cognitive impairment exists in two separate forms 5AIDS-related cognitive impairment exists in two separate forms 6AIDS-related cognitive impairment exists in two separate forms 7Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 2Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 3Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 4Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 5Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 6Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers 7
Platypus Contact Printing Kit contains choice of PDMS Stamps (3 PDMS micropatterned stamps with series of 100 / 200 micron squares or 100 um x 10 mm or 200 um x 10 mm lines, 3 PDMS nano-patterned sta
Creatinine Colorimetric Assay Kit from R&D Systems
...ACHaBEAD Mouse CD4, polyclonal Sheep anti-Mouse Fa...se CD4 (L3T4). Detach positively isolated mosue C...BEAD Mouse CD4. The isolated cells are suitable fo...try, functional studies and expansion using the Dy...
RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein
Biology Products: